Abstract
The November 2014 Food and Drug Administration (FDA) safety communication statement against the use of laparoscopic power morcellators in the “majority of women” undergoing surgery for uterine fibroids (http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm424443.htmaccessed) sent a large ripple through the field of minimally invasive gynecologic surgery (MIGS). With heightened media scrutiny and concern for legal ramifications, not only did multiple hospitals in the US take the device off the shelves, but also some insurance companies now require prior authorization or refuse coverage altogether when power morcellation is used. One of the largest manufacturers of the device subsequently discontinued its production, limiting options for both surgeons and patients. Extracorporeal Manual Morcellation of Very Large Uteri Within an Enclosed Endoscopic Bag: Our 5-Year ExperienceJournal of Minimally Invasive GynecologyVol. 23Issue 6PreviewTo describe a technique to manually morcellate large uteri within a polyurethane endoscopic bag at the time of laparoscopic hysterectomy, and report perioperative outcomes from our 5 years of experience. Full-Text PDF
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
